Most Recent
South Korean biosimilars company Samsung Bioepis has sued Johnson & Johnson's Janssen Biotech to invalidate two patents for Crohn's disease drug Stelara, after reaching a licencing agreement over the medicine in the US.
It's a case of déjà vu in a class action against engineering services company Worley, with shareholders heading back to the appeals court after losing a second trial in their drawn out fight over disclosure breaches.
US consumer goods giant 3M is facing a possible class action on behalf of members of the Australian Defence Force who allegedly suffered hearing loss from defective combat earplugs.
A director of defunct investment scheme A One Multi, which allegedly raised $25 million in funds, has been charged with nine counts of running a financial services company without a licence.
The latest appointment to the Federal Circuit and Family Court is a proud Territorian who will serve with "empathy and enthusiasm", Australia's peak legal body said Monday.
Thomson Geer has recruited new partners from Gadens and Holding Redlich to strengthen the law firm's IP and corporate benches.
A professor from Texas has no business offering an opinion on the meaning of One Nation senator Pauline Hanson's exhortation to the Greens party deputy leader that she "piss off back to Pakistan", a court has heard.
The top judge in NSW has called for more court resources and funding to ease the burden of an overworked judiciary, in an impassioned speech backed by the state's solicitors and barristers.
A law firm that lost a contest to run a class action against Toyota unit Hino has appealed a decision to give the case to a larger rival based on past experience, saying the ruling would act as a deterrent to smaller firms wanting to enter the market for group proceedings.
Finish detergent maker Reckitt Benckiser has thrown the latest punch in a long-running grudge match against rival Proctor & Gamble, with RB challenging a ruling that it made misleading claims about its popular dishwashing product.